Europe Digital Therapeutic (DTx) Market - Industry Trends and Forecast to 2031

TABLE OF CONTENTS

1 INTRODUCTION 16

• 1.1 OBJECTIVES OF THE STUDY 16
• 1.2 MARKET DEFINITION 16
• 1.3 OVERVIEW OF THE EUROPE DIGITAL THERAPEUTICS (DTX) MARKET 16
• 1.4 LIMITATIONS 18
• 1.5 MARKETS COVERED 18

2 MARKET SEGMENTATION 20

• 2.1 MARKETS COVERED 20
• 2.2 GEOGRAPHICAL SCOPE 21
• 2.3 YEARS CONSIDERED FOR THE STUDY 21
• 2.4 CURRENCY AND PRICING 21
• 2.5 DBMR TRIPOD DATA VALIDATION MODEL 22
• 2.6 MULTIVARIATE MODELLING 25
• 2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE 25
• 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
• 2.9 DBMR MARKET POSITION GRID 27
• 2.10 MARKET APPLICATION COVERAGE GRID 28
• 2.11 VENDOR SHARE ANALYSIS 29
• 2.12 SECONDARY SOURCES 30
• 2.13 ASSUMPTIONS 30

3 EXECUTIVE SUMMARY 31

4 PREMIUM INSIGHT 33

• 4.1 PESTEL ANALYSIS 34
• 4.2 PORTER'S FIVE FORCES 35

5 MARKET OVERVIEW 36

• 5.1 DRIVERS 38
  • 5.1.1 RISING TECHNOLOGICAL ADVANCEMENTS IN DIGITAL HEALTHCARE DEVICES 38
  • 5.1.2 INTEGRATION OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) 38
  • 5.1.3 INCREASING GOVERNMENT SUPPORT AND FUNDING 39
• 5.2 RESTRAINTS 40
  • 5.2.1 DATA SECURITY AND PRIVACY CONCERNS RELATED TO DATA 40
  • 5.2.2 HIGH LITERACY GAP IN DIGITAL HEALTH WITHIN THE POPULATION 40
• 5.3 OPPORTUNITIES 41
  • 5.3.1 GROWING EXPANSION OF TELEHEALTH APPLICATIONS IN EUROPE 41
  • 5.3.2 INCREASING FOCUS ON PERSONALIZED DEVICES FOR DIGITAL THERAPEUTICS 42
  • 5.3.3 INCREASING STRATEGIC COLLABORATIONS AMONG THE MARKET PLAYERS 42
• 5.4 CHALLENGES 43
  • 5.4.1 SOFTWARE INCOMPATIBILITY ISSUES DUE TO VARYING DATA STANDARDS 43
  • 5.4.2 REGULATORY AND LEGAL CHALLENGES RELATED TO DTX DEVICES 44

6 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT 45

• 6.1 OVERVIEW 46
• 6.2 SOLUTIONS/SOFTWARE 49
  • 6.2.1 MOBILE APPLICATIONS 49
  • 6.2.2 WEB BASED PLATFORMS 49
  • 6.2.3 ELECTRONIC HEALTH RECORDS 49
  • 6.2.4 OTHERS 49
• 6.3 HARDWARE PRODUCTS 50
  • 6.3.1 WEARABLE DEVICES 50
  • 6.3.2 REMOTE PATIENT MONITORING DEVICES 50
• 6.4 SERVICES 50

7 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION 51

• 7.1 OVERVIEW 52
• 7.2 PREVENTIVE 55
  • 7.2.1 OBESITY 55
  • 7.2.2 PREDIABETES 55
  • 7.2.3 OTHERS 55
• 7.3 TREATMENT 55
  • 7.3.1 CARDIOVASCULAR 56
  • 7.3.2 MENTAL HEALTH 56
  • 7.3.3 DIABETES 56
  • 7.3.4 RESPIRATORY CARE 56
• 7.4 OTHERS 56

8 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL 57

• 8.1 OVERVIEW 58
• 8.2 DIRECT TENDER 61
• 8.3 RETAIL SALES 61
• 8.4 OTHERS 61

9 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER 62

• 9.1 OVERVIEW 63
• 9.2 HOSPITALS 66
• 9.3 SPECIALTY CLINICS 66
• 9.4 HOME HEALTHCARE 66
• 9.5 OTHER 66

10 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY 67

• 10.1 EUROPE 67
  • 10.1.1 GERMANY 69
  • 10.1.2 FRANCE 71
  • 10.1.3 ITALY 73
  • 10.1.4 SPAIN 75
  • 10.1.5 U.K. 77
  • 10.1.6 SWITZERLAND 79
  • 10.1.7 NETHERLANDS 81
  • 10.1.8 RUSSIA 83
  • 10.1.9 TURKEY 85
  • 10.1.10 POLAND 87
  • 10.1.11 SWEDEN 89
  • 10.1.12 BELGIUM 91
  • 10.1.13 DENMARK 93
  • 10.1.14 FINLAND 95
  • 10.1.15 NORWAY 97
  • 10.1.16 REST OF EUROPE 99

11 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, COMPANY LANDSCAPE 100

• 11.1 COMPANY SHARE ANALYSIS: EUROPE 100

12 SWOT ANALYSIS 101

13 COMPANY PROFILE 102

• 13.1 HEALTHHERO 102
  • 13.1.1 COMPANY SNAPSHOT 102
  • 13.1.2 SERVICE PORTFOLIO 102
  • 13.1.3 RECENT DEVELOPMENT 102
• 13.2 RESMED 103
  • 13.2.1 COMPANY SNAPSHOT 103
  • 13.2.2 REVENUE ANALYSIS 103
  • 13.2.3 PRODUCT PORTFOLIO 104
  • 13.2.4 RECENT DEVELOPMENT 104
• 13.3 GAIA AG 105
  • 13.3.1 COMPANY SNAPSHOT 105
  • 13.3.2 PRODUCT PORTFOLIO 105
  • 13.3.3 RECENT DEVELOPMENT 106
• 13.4 SIDEKICK HEALTH GMBH 107
  • 13.4.1 COMPANY SNAPSHOT 107
  • 13.4.2 PRODUCT PORTFOLIO 107
  • 13.4.3 RECENT DEVELOPMENT 107
• 13.5 KAIA HEALTH 108
  • 13.5.1 COMPANY SNAPSHOT 108
  • 13.5.2 PRODUCT PORTFOLIO 108
  • 13.5.3 RECENT DEVELOPMENT 108
• 13.6 MINDABLE HEALTH GMBH 109
  • 13.6.1 COMPANY SNAPSHOT 109
  • 13.6.2 PRODUCT PORTFOLIO 109
  • 13.6.3 RECENT DEVELOPMENT 109

14 QUESTIONNAIRE 110

15 RELATED REPORTS 113

LIST OF TABLES

• TABLE 1 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 48
• TABLE 2 EUROPE SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 49
• TABLE 3 EUROPE HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 50
• TABLE 4 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 54
• TABLE 5 EUROPE PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 55
• TABLE 6 EUROPE TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 55
• TABLE 7 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 60
• TABLE 8 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 65
• TABLE 9 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY COUNTRY, 2022-2031 (USD MILLION) 68
• TABLE 10 GERMANY DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 69
• TABLE 11 GERMANY SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 69
• TABLE 12 GERMANY HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 69
• TABLE 13 GERMANY DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 69
• TABLE 14 GERMANY PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 70
• TABLE 15 GERMANY TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 70
• TABLE 16 GERMANY DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 70
• TABLE 17 GERMANY DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 70
• TABLE 18 FRANCE DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 71
• TABLE 19 FRANCE SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 71
• TABLE 20 FRANCE HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 71
• TABLE 21 FRANCE DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 71
• TABLE 22 FRANCE PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 72
• TABLE 23 FRANCE TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 72
• TABLE 24 FRANCE DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 72
• TABLE 25 FRANCE DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 72
• TABLE 26 ITALY DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 73
• TABLE 27 ITALY SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 73
• TABLE 28 ITALY HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 73
• TABLE 29 ITALY DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 73
• TABLE 30 ITALY PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 74
• TABLE 31 ITALY TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 74
• TABLE 32 ITALY DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 74
• TABLE 33 ITALY DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 74
• TABLE 34 SPAIN DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 75
• TABLE 35 SPAIN SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 75
• TABLE 36 SPAIN HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 75
• TABLE 37 SPAIN DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 75
• TABLE 38 SPAIN PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 76
• TABLE 39 SPAIN TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 76
• TABLE 40 SPAIN DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 76
• TABLE 41 SPAIN DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 76
• TABLE 42 U.K. DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 77
• TABLE 43 U.K. SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 77
• TABLE 44 U.K. HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 77
• TABLE 45 U.K. DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 77
• TABLE 46 U.K. PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 78
• TABLE 47 U.K. TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 78
• TABLE 48 U.K. DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 78
• TABLE 49 U.K. DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 78
• TABLE 50 SWITZERLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 79
• TABLE 51 SWITZERLAND SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 79
• TABLE 52 SWITZERLAND HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 79
• TABLE 53 SWITZERLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 79
• TABLE 54 SWITZERLAND PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 80
• TABLE 55 SWITZERLAND TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 80
• TABLE 56 SWITZERLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 80
• TABLE 57 SWITZERLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 80
• TABLE 58 NETHERLANDS DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 81
• TABLE 59 NETHERLANDS SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 81
• TABLE 60 NETHERLANDS HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 81
• TABLE 61 NETHERLANDS DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 81
• TABLE 62 NETHERLANDS PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 82
• TABLE 63 NETHERLANDS TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 82
• TABLE 64 NETHERLANDS DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 82
• TABLE 65 NETHERLANDS DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 82
• TABLE 66 RUSSIA DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 83
• TABLE 67 RUSSIA SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 83
• TABLE 68 RUSSIA HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 83
• TABLE 69 RUSSIA DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 83
• TABLE 70 RUSSIA PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 84
• TABLE 71 RUSSIA TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 84
• TABLE 72 RUSSIA DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 84
• TABLE 73 RUSSIA DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 84
• TABLE 74 TURKEY DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 85
• TABLE 75 TURKEY SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 85
• TABLE 76 TURKEY HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 85
• TABLE 77 TURKEY DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 85
• TABLE 78 TURKEY PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 86
• TABLE 79 TURKEY TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 86
• TABLE 80 TURKEY DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 86
• TABLE 81 TURKEY DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 86
• TABLE 82 POLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 87
• TABLE 83 POLAND SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 87
• TABLE 84 POLAND HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 87
• TABLE 85 POLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 87
• TABLE 86 POLAND PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 88
• TABLE 87 POLAND TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 88
• TABLE 88 POLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 88
• TABLE 89 POLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 88
• TABLE 90 SWEDEN DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 89
• TABLE 91 SWEDEN SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 89
• TABLE 92 SWEDEN HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 89
• TABLE 93 SWEDEN DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 89
• TABLE 94 SWEDEN PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 90
• TABLE 95 SWEDEN TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 90
• TABLE 96 SWEDEN DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 90
• TABLE 97 SWEDEN DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 90
• TABLE 98 BELGIUM DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 91
• TABLE 99 BELGIUM SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 91
• TABLE 100 BELGIUM HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 91
• TABLE 101 BELGIUM DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 91
• TABLE 102 BELGIUM PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 92
• TABLE 103 BELGIUM TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 92
• TABLE 104 BELGIUM DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 92
• TABLE 105 BELGIUM DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 92
• TABLE 106 DENMARK DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 93
• TABLE 107 DENMARK SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 93
• TABLE 108 DENMARK HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 93
• TABLE 109 DENMARK DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 93
• TABLE 110 DENMARK PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 94
• TABLE 111 DENMARK TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 94
• TABLE 112 DENMARK DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 94
• TABLE 113 DENMARK DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 94
• TABLE 114 FINLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 95
• TABLE 115 FINLAND SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 95
• TABLE 116 FINLAND HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 95
• TABLE 117 FINLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 95
• TABLE 118 FINLAND PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 96
• TABLE 119 FINLAND TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 96
• TABLE 120 FINLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 96
• TABLE 121 FINLAND DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 96
• TABLE 122 NORWAY DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 97
• TABLE 123 NORWAY SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 97
• TABLE 124 NORWAY HARDWARE PRODUCTS IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 97
• TABLE 125 NORWAY DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 97
• TABLE 126 NORWAY PREVENTIVE IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 98
• TABLE 127 NORWAY TREATMENT IN DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE, 2022-2031 (USD MILLION) 98
• TABLE 128 NORWAY DIGITAL THERAPEUTICS (DTX) MARKET, BY END USER, 2022-2031 (USD MILLION) 98
• TABLE 129 NORWAY DIGITAL THERAPEUTICS (DTX) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 98
• TABLE 130 REST OF EUROPE DIGITAL THERAPEUTICS (DTX) MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 99

LIST OF FIGURES

• FIGURE 1 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: SEGMENTATION 20
• FIGURE 2 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: DATA TRIANGULATION 22
• FIGURE 3 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: DROC ANALYSIS 23
• FIGURE 4 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 24
• FIGURE 5 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: COMPANY RESEARCH ANALYSIS 24
• FIGURE 6 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: MULTIVARIATE MODELLING 25
• FIGURE 7 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: INTERVIEW DEMOGRAPHICS 26
• FIGURE 8 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: DBMR MARKET POSITION GRID 27
• FIGURE 9 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: MARKET APPLICATION COVERAGE GRID 28
• FIGURE 10 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: VENDOR SHARE ANALYSIS 29
• FIGURE 11 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: SEGMENTATION 32
• FIGURE 12 RISING TECHNOLOGICAL ADVANCEMENTS IN THE DISEASE DIAGNOSIS AND TREATMENT APPROACH, INCREASING INVESTMENT IN EARLY STAGE VENTURES, REIMBURSEMENT COVERAGE PROVIDED BY THE REGULATORY AGENCIES ARE SOME OF THE FACTORS EXPECTED TO DRIVE THE EUROPE DIGITAL THERAPEUTICS MARKET IN THE FORECAST PERIOD 2024 TO 2031 33
• FIGURE 13 SOLUTIONS/ SOFTWARES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE DIGITAL THERAPEUTICS (DTX) MARKET IN 2024 AND 2031 33
• FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE DIGITAL THERAPEUTICS (DTX) MARKET 37
• FIGURE 15 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY PRODUCT, 2023 46
• FIGURE 16 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY PRODUCT, 2024-2031 (USD MILLION) 47
• FIGURE 17 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY PRODUCT, CAGR (2024-2031) 47
• FIGURE 18 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY PRODUCT, LIFELINE CURVE 48
• FIGURE 19 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY APPLICATION, 2023 52
• FIGURE 20 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY APPLICATION, 2024-2031 (USD MILLION) 53
• FIGURE 21 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY APPLICATION, CAGR (2024-2031) 53
• FIGURE 22 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY APPLICATION, LIFELINE CURVE 54
• FIGURE 23 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY DISTRIBUTION CHANNEL, 2023 58
• FIGURE 24 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION) 59
• FIGURE 25 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031) 59
• FIGURE 26 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 60
• FIGURE 27 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY END USER, 2023 63
• FIGURE 28 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY END USER, 2024-2031 (USD MILLION) 64
• FIGURE 29 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY END USER, CAGR (2024-2031) 64
• FIGURE 30 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: BY END USER, LIFELINE CURVE 65
• FIGURE 31 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: SNAPSHOT (2023) 67
• FIGURE 32 EUROPE DIGITAL THERAPEUTICS (DTX) MARKET: COMPANY SHARE 2023 (%) 100